Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification

Paula Saá1, Joaquín Castilla, Claudio Soto

  • 1George and Cynthia Mitchell Center for Alzheimer Disease and Related Neurodegenerative Disorders, Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555, USA.

Insights

Protein misfolding cyclic amplification (PMCA) technology can amplify minute quantities of misfolded prion protein (PrPSc) in vitro. This breakthrough allows for the detection of single infectious prion particles, aiding in early disease diagnosis.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Infectious Diseases

Background:

  • Prions, composed of misfolded prion protein (PrPSc), cause transmissible spongiform encephalopathies.
  • Prion replication involves converting normal prion protein (PrPC) to the misfolded PrPSc isoform.
  • Existing detection methods for PrPSc lack sufficient sensitivity.

Purpose of the Study:

  • To demonstrate the efficacy of protein misfolding cyclic amplification (PMCA) for amplifying PrPSc in vitro.
  • To assess the sensitivity and specificity of PMCA for detecting minute quantities of infectious prions.
  • To evaluate the infectivity of in vitro-amplified PrPSc.

Main Methods:

  • Utilized protein misfolding cyclic amplification (PMCA) technology for prion replication.
  • Amplified PrPSc from highly diluted scrapie hamster brain samples.
  • Inoculated amplified PrPSc into wild-type hamsters to assess infectivity.

Main Results:

  • PMCA successfully amplified PrPSc from extremely low concentrations, equivalent to approximately 26 molecules.
  • The technology demonstrated the potential to detect single oligomeric PrPSc infectious particles.
  • In vitro-generated PrPSc was infectious in hamsters, causing disease identical to natural prion infections.
  • PMCA achieved a billion-fold increase in sensitivity compared to standard tests and 4000-fold over animal bioassays.

Conclusions:

  • PMCA technology enables highly sensitive and specific amplification of infectious prions in vitro.
  • PMCA holds significant promise for the early diagnosis of transmissible spongiform encephalopathies.
  • This method provides a valuable tool for understanding the molecular mechanisms of prion propagation.